Eu­ro­pean in­vest­ment group clos­es €260M raise for de­men­tia fund

Health­care in­vest­ment group EQT Life Sci­ences raised ap­prox­i­mate­ly €260 mil­lion to in­vest in com­pa­nies work­ing on neu­rode­gen­er­a­tive dis­eases.

The orig­i­nal tar­get fund size was €100 mil­lion, but the fund sur­passed that, hit­ting the hard cap at €260 mil­lion. The fund will be used to in­vest in com­pa­nies de­vel­op­ing drugs and med­ical tech­nolo­gies.

In­vestors in­clud­ed the Alzheimer’s As­so­ci­a­tion, the Eu­ro­pean In­vest­ment Fund, “sev­er­al” un­named glob­al phar­mas, as well as en­dow­ments and foun­da­tions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER